AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ELEMENT BIOSCIENCES · Biotechnology

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$39,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025

Medical/Disease Research/Clinical Labs

- National Security Commission on Emerging Biotechnology

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.